Re: Pre-Exposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Re: Pre-Exposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.

Morenike Oluwatoyin Folayan, Bridget Haire, Veronica Noseda

Author Information

Morenike Oluwatoyin Folayan: Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria.
Bridget Haire: Kirby Institute, University of New South Wales, Sydney, Australia.
Veronica Noseda: Vaccine Advocacy Resource Group, Durban, South Africa.

PMID: 31505662 DOI: 10.1093/infdis/jiz263

No abstract text available.

Anti-HIV Agents

HIV Infections

HIV-1

Humans

Pre-Exposure Prophylaxis

Sexual Partners

Anti-HIV Agents

Letter Comment

Preexposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.Partner protections in HIV cure-related trials involving analytical treatment interruption: Updated toolkit to mitigate HIV transmission risk.Enhanced risk of HIV sexual transmission during structured treatment interruption.[Pre-exposure prophylaxis for HIV transmission? No, unless].HIV: Pre-exposure Prophylaxis.HIV Pre-Exposure Prophylaxis.HIV pre-exposure prophylaxis.HIV pre-exposure prophylaxis.Drug Resistance During HIV Pre-Exposure Prophylaxis.Pre-exposure prophylaxis of HIV.

A partner protection package for HIV cure-related trials involving analytical treatment interruptions.